Background and Aims MET the hepatocyte growth factor receptor is a receptor tyrosine kinase overexpressed and activated in a subset of gastric cancer. that explored the association between MET amplification and expression with survival in patients with gastric cancer up to at least one 1 April 2013 Data of individual hazard ratios (HRs) and 95%… Continue reading Background and Aims MET the hepatocyte growth factor receptor is a